We demonstrated that the null polymorphism of GSTM1 was associated with a significant increase in overall childhood acute leukemia risk, whereas the null polymorphism of GSTT1 did not appear to have an overall influence on the susceptibility of childhood acute leukemia. This evidence concerns the gene GSTM1 and acute leukemia.